The House of Representatives Plans a Vote on Insulin Cap Legislation


The U.S House of Representatives intends to vote on a bill later this week to cap the cost of an insulin co-pay at $35 for privately insured and Medicare patients. The bill, HR 6833, the Affordable Insulin Now Act, is an effort by Democrats to lower the rising costs of prescription drugs. After the bill moves through the House, the Senate plans to take up the bill and pair it with a yet to be determined bipartisan proposal that would target Pharmacy Benefit Managers to lower the price of insulin.